These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9406905)

  • 1. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Psychiatry Res; 1997 Oct; 72(3):161-6. PubMed ID: 9406905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant cognitive factors in responder and non-responder patients with schizophrenia.
    Stip E; Lussier I; Ngan E; Mendrek A; Liddle P
    Eur Psychiatry; 1999 Dec; 14(8):442-50. PubMed ID: 10683630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia.
    Rodriguez VM; Catalina ML; García-Noblejas JA; Cuesta P
    Psychiatry Res; 1998 Jan; 77(1):21-8. PubMed ID: 10710171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms.
    Brar JS; Chengappa KN; Parepally H; Sandman AR; Kreinbrook SB; Sheth SA; Ganguli R
    Ann Clin Psychiatry; 1997 Dec; 9(4):227-34. PubMed ID: 9511946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine: efficacy and safety.
    Buchanan RW
    Schizophr Bull; 1995; 21(4):579-91. PubMed ID: 8749886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA; Buckley PF; Meltzer HY
    J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clozapine on physical and verbal aggression.
    Rabinowitz J; Avnon M; Rosenberg V
    Schizophr Res; 1996 Dec; 22(3):249-55. PubMed ID: 9000322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.
    Bora E; Veznedaroğlu B; Kayahan B
    Clin Neuropharmacol; 2005; 28(3):139-41. PubMed ID: 15965314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Weight gain and clozapine].
    Jalenques I; Tauveron I; Albuisson E; Audy V
    Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of clozapine on the speed and accuracy of information processing in schizophrenia.
    Galletly CA; Clark CR; McFarlane AC; Weber DL
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1329-38. PubMed ID: 11125857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients.
    Ertugrul A; Anil Yagcioglu AE; Eni N; Yazici KM
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):219-22. PubMed ID: 15823172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine plus lamotrigine in treatment-resistant schizophrenia.
    Dursun SM; McIntosh D; Milliken H
    Arch Gen Psychiatry; 1999 Oct; 56(10):950. PubMed ID: 10530638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.